Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study

Table 1

Descriptive analysis of the HT1 sociodemographic characteristics.

	Frequency	Percentage
Gender
Female	9	50
Male	9	50
Classification of HT1 based on the age of symptom onset
Acute (<6 months)	12	66.7
Subacute (6-12 months)	5	27.8
Chronic (>12 months)	1	5.6
Survival
Alive	16	88.9
Died	2	11.1
Age (years) at the study time, mean (SD)	6.03 (3.85)
Age (months) at symptom onset, mean (SD)	5.61 (6.02)
Age (months) at diagnosis time, mean (SD)	10.50 (10.42)
Age (months) at the commencement of NTCB therapy, mean (SD)	20.33 (25.97)
The interval (months) between diagnosis and initiation of NTCB therapy, mean (SD)	12.28 (25.36)